-
effectivehealthcare.ahrq.gov/health-topics/rehabilitation
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - Among 2472 patients
evaluated at 1 year and 1127 evaluated at 2 years, the rate of cardiac
17 … cardiovascular outcomes trial (CVOT) to assess the effects of
the drug on the risk of major adverse cardiac … fenfluramine and
dexfenfluramine), were withdrawn from the market because of their association with cardiac … fenfluramine and dexfenfluramine, were
withdrawn from the market because of their association with cardiac … However, data from at least one study suggests lorcaserin may
not increase cardiac valvular disease
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - as a
proxy the average cost of new and novel cardiac valves or devices that entered the U.S. market … presenting
cardiology research
X X X X X X X
36 European Society of Cardiology’s
(ESC) Acute Cardiac … Care
1, 11
Annual meeting presenting
research on treatments of acute
cardiac conditions
X X X … X X X X
37 Heart Rhythm Society (HRS)
1, 11
Annual meeting presenting
research on cardiac rhythm … Society for Cardiovascular
Angiography and Interventions
(SCAI)
1, 11
Annual meeting covering
cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - as a
proxy the average cost of new and novel cardiac valves or devices that entered the U.S. market … presenting
cardiology research
X X X X X X X
36 European Society of Cardiology’s
(ESC) Acute Cardiac … Care
1, 11
Annual meeting presenting
research on treatments of acute
cardiac conditions
X X X … X X X X
37 Heart Rhythm Society (HRS)
1, 11
Annual meeting presenting
research on cardiac rhythm … Society for Cardiovascular
Angiography and Interventions
(SCAI)
1, 11
Annual meeting covering
cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
August 01, 2012 - the help of an eight-person Key Informant group
representing clinicians (cardiology, primary care, cardiac … Literature flow diagram
19
baseline clinical characteristics (e.g., age, diabetes, sex,
individual cardiac … clinical evaluation of women with suspected coronary artery
disease: consensus statement from the Cardiac … there a gender
difference in risk profile, attendance, and beneficial effects of a
multidisciplinary cardiac … Cardiac syndrome X. In: Wenger NK and Collins P, eds.
Women and heart disease. 2nd ed.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
December 15, 2010 - enzyme.13 This enzyme is involved in the oxidative metabolism of many
synthetic drugs,14-20 including cardiac … how the review will differentiate between varying
effects of drug-supplement combinations, as most cardiac … Herbal therapies and cardiac side effects. Prog Cardiovasc Nurs 2008;23:187-90.
17.
-
effectivehealthcare.ahrq.gov/health-topics/electrical-injuries
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
January 01, 2022 - treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 (95% CI 0.47 to 0.77)
Cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
January 01, 2022 - treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 (95% CI 0.47 to 0.77)
Cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
February 02, 2022 - factors
(hypertension,
diabetes,
hyperlipidemia,
tobacco use,
obesity, physical
inactivity)
● Cardiac … Near-miss maternal mortality:
cardiac dysfunction as the principal cause of obstetric intensive care
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
January 01, 2014 - presence of either ST segment
depression or T-wave inversion on
electrocardiography and/or abnormal
cardiac … NSTEMI is broadly classified as
upstream if the therapy is initiated after admission but
prior to cardiac … consists of an oral antiplatelet agent or intravenous
(IV) GPI as initial therapy prior to going to the cardiac … Intravenous GPI (select one)
– Eptifibatide
– Tirofiban
– Abciximab
Cardiac … , with greater use of
conservative, medically managed approaches in countries
with less access to cardiac
-
effectivehealthcare.ahrq.gov/products/acs-pci-adjunctive-devices/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
January 01, 2018 - Tricyclic Antidepressants - Placebo-Controlled Trials
WAE WAE SAE SAE Cardiac Rhythm Abnormalities … Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cognitive Effects
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
August 16, 2016 - 3 indications for
renal intervention: 1 renovascular hypertension; 2
ischemic nephropathy; and 3 cardiac … improvement in
uncontrolled HTN, preservation or salvage
of kidney function, prevention or treatment
of cardiac … or severity of CHF following medical or
interventional therapy for RAS in patients with unstable
cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
March 01, 2009 - Favorable cardiac risk among elderly breast
carcinoma survivors. Cancer 2003;98(1):2-10. … Cardiac and vascular morbidity in
women receiving adjuvant tamoxifen for breast cancer in a randomised … Comparison of the effects of tibolone and
estrogen replacement therapy on echocardiographic basic cardiac … Rate
Veronesi, 200729:
21 2.01 35 3.48 1.73 1.01-2.98 Cardiac Arrhythmias, Atrial
Fibrillation … 64 2.37 1.15 0.81-1.64 Checklist of predefined side
effects asked directly during
main trial
All cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
May 01, 2016 - Avoid use in patients with known structural
cardiac abnormalities, cardiomyopathy, serious heart arrhythmia
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
February 01, 2011 - diabetes are expected to suffer from several associ-
ated medical complications, such as renal disease, cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
May 01, 2024 - center
China
Intervention: 1,757
Control: 530
Active surveillance
of all patients
undergoing cardiac … of
preoperative Staphylococcus aureus screening
and targeted decolonization bundle protocols
in cardiac … 202219 Retrospecti
ve cohort
Examine the
prevalence of
MRSA
colonization in
patients prior to
cardiac … Shanghai
Jiao Tong
University
School of
Medicine
Active surveillance
of all patients
undergoing
cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
July 01, 2023 - The New York State cardiac registries: history,
contributions, limitations, and lessons for future efforts
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
October 01, 2007 - The
demographic characteristics and cardiac risk factor
profiles of trial participants were typical of … left main or left main equivalent disease randomized to PCI
supported by retroinfusion of the anterior cardiac